The binding of TROY to EGFR enhanced the continuous expression of the EGFR signal by delaying EGFR endocytosis and promoted invasion of glioblastoma cells through TROY-induced activation of NF-κB (Ding et al., 2018). This evidence concerns the gene TNFRSF19 and glioblastoma.